My Photo
People's HealthBlogger Award - Help Vanessa win!

NFCA Tips

$$$ 4 Celiac

Tip Jar

Google Ads

Enter your email address:

Delivered by FeedBurner

Celiac Research

January 27, 2009

Rising Medication Costs & Gluten in Medications

A new report from the Washington, DC-based Center for Studying Health System Change finds that one in seven Americans under the age of 65 went without a necessary prescription medication in 2007, largely because of skyrocketing drug costs.

Now, you're probably thinking that the report applies to people who are uninsured...at least that's what I thought when I first looked at the report. But the study actually found that even people with private health insurance provided by their employers went without much needed medications. In fact, one in 10 working Americans with employer-sponsored health insurance chose not to take a prescription drug in 2007, up from only 8.7 percent in 2003. Why? According to study researchers, the most common reasons were rising drug prices, the introduction of new and more expensive specialty medications to the market, and "skimpier drug coverage that shifts a greater share of costs onto patients."

How does this affect people with celiac disease and those on a gluten-free diet? It's simple and it actually hit me right in the pocketbook just a couple of months ago.

I had what I thought was really good health insurance provided by my employer. But one case of pneumonia later and I found out it wasn't all that fabulous. My doctor prescribed an antibiotic to me that she described as a "bull-dog" to knock out the infection. She had also recently prescribed the same drug to another celiac patient and had already verified with the company that the medication was in fact gluten-free. Yay! What a sense of relief!

I took the prescription to the pharmacy, provided them with my insurance card and waited 20 minutes for it to be filled. When they called my name, I was thrilled and couldn't wait to swallow the first pill and get on the road to feeling better. But as the pharmacist rang me up, my jaw dropped and I almost started crying. The total for one prescription was $187.36. I couldn't believe it. I politely asked the pharmacist if she had run it through my insurance since I always paid $15 for every prescription. She kindly said yes and informed me that the medication was a tier 2 drug (or something like that) and that my insurance would only cover a small percent unless my doctor could prove that I had to take this particular drug over a less expensive alternative like a generic.

So thus began a chase to track down my doctor, explain the situation and try to get the insurance company to cover the antibiotic. The first problem we ran into was finding a medication that we could verify was gluten-free. I'm allergic to penicillin and all of its relatives and my doctor was unsure about the inactive ingredients in a lower-cost generic antibiotic. She waited about 12 hours to hear back from the drug company before telling me that I had to start taking the medication. The pneumonia was a worse predicament than possibly having a reaction to the gluten. So, this lower-cost alternative still cost me $56, but well, that's better than the original price.

Roughly 24 hours after I started taking the medication, my good friends at the Drug Information Center at St. Johns University College of Pharmacy were able to verify that the drug was gluten-free and safe for me to continue taking.

So, what's the moral of the story? First of all, we desperately need health care reform in the United States so that everyone has access to quality, affordable coverage. We need regulation of the insurance industry so everyone with celiac and other chronic diseases can have easy access to safe, gluten-free medication at the same prices as other drugs. Until that happens, here are a few great resources that will help you quickly determine the gluten content of medications:

Gluten-Free Drugs:
a site maintained by Columbus Children's Hospital
www.glutenfreedrugs.com

American Society of Health System Pharmacists
An organization of 35,000 pharmacists working in hospitals, Download the Gluten in Medications Flyer for information about how you can help your pharmacist and doctor find safe drugs.
www.ashp.org

November 20, 2008

Study Verifies Link Between Celiac & Thyroid Disease

Research to better understand celiac disease is underway around the globe. With each published study we learn more about how the autoimmune disease affects patients and how groundbreaking therapies may, in the near future, make it easier to manage a gluten-free diet.

This fall there was one study in particular that peaked my interest.

The research was published in the October issue of the Journal of Clinical Endocrinology & Metabolism and examined the risk of thyroid disease in patients with celiac disease.

Before I get into the results, let's take a step back and understand what thyroid disease is, how it is diagnosed and treated.

The thyroid is a small gland located in the middle of your lower neck. Its primary purpose is to control your body's metabolism by producing hormones that regulate the amount of energy the body needs to use in order to maintain a functioning metabolism rate.

There are several different types of thyroid disease. Autoimmune Thyroiditis, also known as Hashimoto's thyroiditis, is the most common type of thyroid condition. Patients with this type of thyroid disorder experience enlarged thyroid glands that do not produce enough hormones. This causes the body to use energy slower than normal.

Conversely, Graves Disease causes hyperthyroidism, which is when the thyroid is overactive and produces too much hormone. This causes the body to use energy much faster than it should.

The most common symptoms of thyroid disease are similar to those associated with celiac disease and include:

  • Fatigue
  • Abnormal menstruation
  • Weight gain or loss
  • Dry and coarse skin & hair
  • Depression
  • Intolerance to cold
  • Irritability
  • Muscle weakness
  • Tremors
  • Vision problems (eye irritation)

Although anyone across all ages, races and genders can develop thyroid diseases, women are five to eight times more likely to develop a thyroid complication than men.

Now, back to the study so you can better understand how this might relate to you or a person you know with celiac disease!

For the study, researchers from the Department of Pediatrics at Orebro University Hospital in Sweden evaluated 14,021 patients with celiac disease and 68,068 healthy individuals. After thorough evaluation, the researchers found that patients with celiac disease were 4.4 times more likely to develop hypothyroidism, 3.6 times more likely to develop thyroiditis and 2.9 times more likely to develop hyperthyroidism than their healthy counterparts.

If the data amongst adults wasn't enough to shock you, the data was even more shocking for children. Celiac children were 6.0 times more likely to develop hypothyroidism, 4.7 times more likely to develop thyroiditis and 4.8 times more likely to develop hyperthyroidism!

The researchers concluded that celiac disease is in fact related to thyroid disease and that patients with celiac disease are more likely than healthy individuals to develop hypothyroidism, thyroiditis, or hyperthyroidism.

So what does this mean for you? If you experience symptoms that you think might be linked to thyroid disease, talk to your doctor immediately. There are several treatments available, so as always, don't wait...get tested!

October 24, 2008

At-Home Celiac Test Coming Soon to U.S. Market

One of the most common complaints I hear from patients is “my doctor won’t test me for celiac disease.”

These are patients who have clear symptoms of celiac disease and should be screened, but can’t get a doctor to acknowledge that celiac is one of the most common conditions in the United States and affects more than 3 million people!

The good news is that within the next year, patients could be able to accurately and easily screen themselves for celiac disease from the comfort of their own home. And, it won’t cost a fortune…only about $50.

For the first time, Health Canada has approved the Biocard Celiac Test Kit, an at-home test that measures (anti-tTG) IgA antibodies from a fingertip blood sample. The U.S. FDA is currently evaluating the test and is expected to grant approval in the United States sometime in 2009. CeliacTestKig

The test comes from 2G Pharma and was developed by two women who are best friends and worked for years in the corporate pharmaceutical world. Their closest friend was diagnosed with celiac disease after more than 10 years of severe suffering from celiac and almost bleeding to death from intestinal damage. The ladies used all of their skills to find and bring to market a test that would prevent anyone from suffering the same pain their friend had while trying to get a celiac diagnosis.The Biocard Celiac test has been approved in Europe since 2005.

So, how does the test work? The Biocard Celiac Test measures the presence of antibodies in the blood.  Certain antibodies in a person’s blood indicate whether or not the body is having an immune system response to the presence of some foreign substance. For people with celiac disease, the foreign substance is gluten! 

The test is simple and quick to administer! And, the company even created a video with step-by-step instructions so that you will be sure to take it correctly. Watch the video! Just be sure that you are consuming a diet containing gluten in order to obtain accurate results.

To take the test, start by setting up all of the different parts of the kit. Gently massage your index  finger to drive blood to it. Then wipe your finger with an alcohol swab and let it dry. Prick your clean fingertip with the lancet that is included in the test kit. It is a very small needle, so it is practically painless. Gently press the blood out of your fingertip into the vile and mix it with the included buffer solution. Turn the vile upside down and mix the blood and buffer together. Then squeeze three drops of the blood/buffer liquid into the sample holder. Wait 10 minutes to read results.

The Biocard Celiac Test is positive if you have two red lines on the test card. One red line appears in the control field, which indicates that you have done the test correctly. The second red line will only appear if you are having an immune system response to the gluten protein. If the test comes out positive for celiac disease, the makers of the test recommend consulting with a doctor to confirm the diagnosis with an intestinal biopsy.

How reliable is the test? According to the creators at 2G Pharma Inc., the test is as accurate as a tissue transglutaminase (tTG) laboratory test that your doctor would request and uses the same technology to detect specific IgA antibodies that react with tissue transglutaminase (tTG), a well known indicator of celiac disease.  The test has been approved by Health Canada and meets all of the European medical device requirements for a home test.

Additionally, a study published in the British Medical Journal found that the simple rapid antibody test allowed nurses working in primary care medical offices to detect celiac disease in patients who were not picked up during routine clinical care. The study evaluated 2,690 children around six years old and 120 nurses. The study found 31 newly diagnosed celiac patients. The rapid test accurately detected celiac disease in 30 of the 31 patients. 

The Biocard Celiac Test is a landmark development for the entire celiac community. It is the first time that patients will have immediate access to find out if they have the autoimmune disorder. It makes celiac disease as easy to diagnose as strep throat!  It will also allow for simple mass screening, especially amongst family members of those already diagnosed.

So, be sure to check back soon—I’ll have all of the details for when the test becomes available in the United States and how you can get it! Also, be sure to keep visiting the National Foundation for Celiac Awareness website to find out how 2G Pharma will be working with the NFCA on several programs in the United States next year!

September 19, 2008

Celiac Disease, Refractory Sprue, Gluten Intolerance & Wheat Allergies?

As the Director of Programming & Communications for the National Foundation for Celiac Awareness, I get the same question several times a day: what is the difference between celiac disease, refractory sprue, gluten intolerance and a wheat allergy.

Last week, I had the privilege of working with Dr. Daniel Leffler from The Celiac Center at Beth Israel Deaconess Medical Center on the Gluten in Medications Educational Session. During his presentation, he gave a very clear and concise explanation of all four that I wanted to share. Read the following definitions closely. There are subtle but very important differences between each of the four. Dr. Leffler's definitions are italicized. My comments are below his.

1. Celiac Disease:
A heightened immune responsiveness to gluten leading to autoimmune intestinal damage often with systemic manifestations.

This means that a person with celiac disease will actually experience an autoimmune response that will result in damage to the villi in the small intestines. This is what leads to malabsorption of nutrients in food and causes a myriad of symptoms such as stomach aches, diarrhea, headaches, skin irritation, pregnancy complications, failure to thrive, gas, constipation, etc.

2. Refractory Celiac Sprue:
Celiac disease that does not respond to gluten withdrawal.

Patients who are diagnosed with refractory sprue may have experienced some improvement with a gluten-free diet, but then relapse. Recent studies suggest that development of refractory sprue represents a "transition state to intestinal lymphoma." Physicians are unsure about the prevalence of refractory sprue and are working to develop therapeutic guidelines for the disease.

3. Gluten Intolerance:
Functional symptoms related to gluten exposure without an immune response/intestinal damage

Gluten intolerance is not celiac disease, rather it is when patients experience symptoms after eating gluten. There is no autoimmune response and no damage caused to the intestines.

4. Wheat Allergy:
Adverse reactions involving IgE antibodies to one or more proteins found in wheat  (No antibodies to self!)

Wheat is considered one of the eight most common allergens in food. A person with a wheat allergy  typically experiences symptoms within a few minutes to hours of consuming wheat. Symptoms can be mild or severe and generally include congestion, skin reaction and digestive problems, but rarely lead to an anaphylactic reaction.

September 17, 2008

Study Relates Celiac Disease and Migraine Headaches

Today is a marvelous day for people with celiac disease. And, it is especially wonderful for me since I suffered for more than 21 years with debilitating migraine headaches. I always thought that migraines just ran in my family. My dad and grandmother got them all the time and I just thought it was somewhat normal to always have a pain in the right side of my head....or at least I thought it was normal until the pain got so bad in college that I could hardly function. I was taking Intravenous prednisone daily (yes, a nurse came to my dorm room to administer it) and was nauseous and miserable all the time until that magical day that I was finally diagnosed with celiac disease.

Within six weeks of being on a a gluten-free diet, my headaches were gone. In my mind, it was truly a miracle. Since my diagnosis, I've told everyone I know who complains about migraine headaches to get tested for celiac disease. Today, I actually have scientific proof to send them that migraine headaches are an indicator of celiac disease! So here you go....published Turkish research about the connection between migraines and celiac!

The study is published in the September issue of the journal Cephalalgia and finds that children who experience migraine headaches have a greater risk of being diagnosed with celiac disease than children without headaches. I was first diagnosed with migraines when I was seven years old, so right in this age group!

Researchers from Baskent University Faculty of Medicine in Turkey studied 73 patients ranging in age from 6 to 17 who complained of migraine headaches and compared them with 147 healthy control patients. They found that 5.5% of the patients reporting migraine headaches tested positive for celiac disease, compared with only 0.6% of patients in the control group. Not all of the patients who received a positive blood test result underwent a biopsy to confirm the diagnosis, so the researchers are considering the findings a "reliable indicator of the presence of celiac disease." 

The researchers concluded that their findings of a higher prevalence of tTGA antibodies in migraine patients "suggests that an association between migraine and celiac disease might exist in the pediatric age group."

Although the researchers note that significantly more research needs to be done, the study is a milestone for thousands of celiac patients who presented only with headache symptoms before receiving a diagnosis.

So...if you know someone who has routine migraine headaches, tell them to get tested for celiac disease! Send them to the National Foundation for Celiac Awareness and tell them to fill out a symptoms checklist and take it to their doctor! You never know...a simple blood test could change your life!

September 15, 2008

Thank You! Gluten in Medications and Boston Gluten-Free Cooking Spree

I just wanted to take a quick moment to thank everyone who attended, participated and helped make the Boston Gluten-Free Cooking Spree and Gluten in Medications educational session a huge success!

At last count, 1001 pharmacists, medical professionals, dietitians and patients attended the Gluten in Medications Educational Session. The event was sponsored by the American Society of Health-System Pharmacists and Stop & Shop. Due to the overwhelmingly positive response and the 130 emails I've gotten with requests to repeat the session, I can assure you that we definitely will hold another event in the near future. So stay tuned and check back for scheduling of the next session!

As for the Boston Gluten-Free Cooking Spree, 421 people from the Boston area came out to show their support for the NFCA and celiac disease awareness programming. I was going to give you a full overview, but I just noticed that one of our attendees already did a tremendous job with this, so here's a link to Jenny's recap! Click Here to read it!

Team #2 (Chef Jason Banusiewicz of Top of the Hub, Dr. Dan Beluk of Harvard Vanguard and Maria Lewis of Stop & Shop) won the cooking competition and were awarded the Best Gluten-Free Dish in Boston Award! The team prepared a delicious Rice Paper Wrapped Salmon with Citrus Soy Glaze, Quinoa & Mango Salad with a Red Curry Cocounut Sauce. It was SOOOO good!

That's all for now, but stay tuned for more about upcoming fabulous events from the National Foundation for Celiac Awareness!

September 08, 2008

Itchy Skin? Celiac Disease and Dermatitis Herpetiformis

We all hate to be itchy. Every time I get a bug bite, I scratch my skin until it bleeds because I can’t stand the itchiness! But a bug bite is a small and almost inconsequential ailment compared to what many of us with celiac disease have to endure if we’re one of the few to experience Dermatitis Herpetiformis (DH), a common complication of the autoimmune disease.

Intense blistering, burning, stinging and itching on the knees, elbows, scalp, back and buttocks are some of the most classic symptoms. This all may sound really gross, but don’t worry….DH is genetically determined and is not contagious!

The name, dermatitis herpetiformis, is a descriptive name and is not related to either dermatitis or herpes, but is a specific chronic skin condition. The rash may occur in the form of small lumps, like insect bites and in some cases form fluid filled blisters. These small blisters are called vesicles. However, the rash may appear hive-like, persisting in one area or another. DH can flare and subside even without treatment. When the rash clears up, which it often does spontaneously, it may leave brown pigmentation or pale areas, where pigmentation is lost.

Diagnosis:
Dermatitis Herpetiformis is diagnosed through a blood test and/or a skin biopsy.

Who Gets Dermatitis Herpetiformis and how does it relate to Celiac Disease?
DH affects males more often than females and generally presents in adult life between the ages of 20 and 55. Although it is quite uncommon to find DH in children, cases have been reported.

Not all people with celiac disease develop dermatitis herpetiformis. According to the National Institutes of Health, only about 20 percent of people with DH have intestinal symptoms of celiac disease. However, Australian researchers say that biopsies show that 80% have some degree of villous atrophy.

How is DH Treated?

Like celiac disease, DH is treated with a lifelong gluten-free diet. It may take about six months to achieve some improvement in the skin condition and up to two years or more to achieve total control by sticking to the gluten-free diet alone. This means that the skin response is much slower compared to the healing of the intestines with celiac disease.

Unlike celiac disease, there are a few other treatments for DH that can help relieve symptoms. The rash symptoms can be controlled with medications such as dapsone. However, dapsone does not treat the intestinal condition, meaning that people with DH must also maintain a lifelong gluten-free diet.

More information & References

  • National Institutes of Health (http://digestive.niddk.nih.gov/ddiseases/pubs/celiac/index.htm)
  • The Coeliac Society of Australia (http://www.coeliacsociety.com.au/dermatitis-herpetiformis.htm)
  • August 11, 2008

    Gluten-Free Food Labeling: The Whole World is Watching and Listening

    Diagnosis of celiac disease is increasing at a rapid pace. According to new research presented at Digestive Disease Week 2008, there have been about 50,000 new celiac cases recorded in the United States in the four years since the NIH Consensus Conference on Celiac Disease.

    Overall, 1 in 133 Americans—about 3 million people—have celiac disease, meaning that gluten-free diets are no longer just a trend but a lifestyle adopted by millions of Americans to treat a medical condition.

    As most of you already know, the only treatment is a 100% gluten-free diet. For those of us with celiac disease, the gluten-free diet can prevent the onset of cancer, osteoporosis, pregnancy complications and other autoimmune diseases. A simple change in diet can save our lives!

    Additionally, Autism Spectrum Disorders affect roughly 1 in 150 children in the United States. A gluten-free casein-free diet has led to dramatic improvement in cognitive abilities amongst some autistic children. And, people with other diseases such as multiple sclerosis and lupus have seem improvement in their symptoms by eliminating wheat, rye and barley from their diets.

    What does this mean? More patients being diagnosed translates into greater demand for gluten-free food. In fact, sales from gluten-free products topped $1.3 billion in 2007 – a 20% increase over previous years. Sales are expected to reach $1.7 billion by 2010.

    Mainstream companies such as General Mills, Anheuser Busch, Giant, Stop & Shop, and event Wal-Mart are expanding into gluten-free markets. Today there are roughly 1,000 gluten-free products on Wal-Mart store shelves.

    To highlight the growth even further, in the 52 weeks ending on February 12, 2008, there were 726 NEW UPC-coded packages with gluten-free claims, compared with only 442 during the same time period in 2005. The total number of gluten-free UPC codes was 3,209 in 2008, up from 1,709 in 2005.

    However, with growth in industry production, comes the need for regulations to ensure that everyone with celiac disease is safe when they purchase food that is labeled gluten-free. The good news is that the entire world is listening and taking action to ensure patient safety. 

    World Health Organization Rulings-1st in 25 Years
    On July 1, 2008, the Codex Alimentarius Commission, a joint body of the World Health Organization, set a new benchmark for gluten-free, dictating that food labeled as gluten-free may not contain more than 20 milligrams per kilogram (20 parts per million) of wheat, rye, barley or oats.

    Former guidelines passed in 1983 stated 500 milligrams per kilogram, but new advancements in technology for testing food products allowed the dramatic shift to 20 milligrams per kilogram.

    The ruling will serve as a global reference for consumers, manufacturers, food processors, national food control agencies and international food traders. Although the standard is non-binding, it will be used and enforced by the 176 member countries and the European Union as they establish globally accepted food safety policies. Consumers with celiac disease will be protected by the standards as countries work the new rule into their national legislation.

    How is the United States Going to Adopt the WHO Guidelines?

    Before we get to what might happen in the United States, lets take a look at the history. The Food Allergy Labeling & Consumer Protection Act of 2004 (FALCPA) required labeling of the eight most common food allergens including milk, eggs, fish, crustacean shellfish, tree nuts, wheat, peanuts and soybeans. All eight must be listed by their common name on the labels of packaged foods. This was a monumental event for everyone in the USA with food allergies and a huge help to people with celiac disease since at least wheat was included on the list. However, the absence of “gluten” on the list has still left celiac patients having to do extensive research to determine if packaged foods are indeed safe.

    Although gluten was not included in FALCPA, a statute within the law directed the Secretary of Health and Human Service to propose and then make a final rule that defines and permits use of the term “gluten-free” for voluntary use on packaged foods.

    To comply with the statute and follow recent acts by the WHO, the FDA is soon expected to define gluten-free for voluntary use in the labeling of foods to mean:

    Food bearing a “gluten-free” claim in its labeling does not contain any one of the following:

    • An ingredient that is a prohibited grain (All species of wheat, rye barley and any crossbred hybrids).
    • An ingredient that is derived from a prohibited grain and that has not been processed to remove gluten.
    • An ingredient that is derived from a prohibited grain and that has been processed to remove gluten, if the use of that ingredient results in the presence of 20 parts per million (ppm) or more gluten in the food.
    • 20 ppm or more gluten.

    **It is important to note that this is still only a proposal. To date, the FDA has not approved a standard.

    Why 20ppm??
    There has been great debate over what the standard for gluten-free should be. The 20ppm level is based on currently available analytic methods.  Data from peer-reviewed scientific literature demonstrates that current analytic technology can reliably and consistently detect gluten in wheat, rye, and barley at levels of 20 ppm in a variety of food structures.

    Why are Oats Excluded from the FDA Proposal?
    Oats have caused a huge controversy for the celiac community. Oats in their natural form do not contain the gluten protein. However, most mills that produce and store oats also manufacture wheat, making the chances of cross contamination inevitable. In addition, current research shows that approximately 1%- 5% of celiac patients react to oats in their pure form. Although the cause for this reaction is unknown, some literature suggests that a protein in oats can trigger a similar response to gluten. However, for the rest of us, oats in their natural form that are produced in a gluten-free facility are safe and can be enjoyed!

    Bob's Red Mill, for example, has gone to great lengths to ensure that their Whole Grain Rolled Oats are prepared and kept safe from contamination. Their oats are grown, transported and processed in entirely gluten-free environments and tested a number of different ways for gluten. With this level of care given to avoiding gluten contamination, most people with celiac disease should be able to safely eat these oats. The back label of the product explains how the oats are prepared and protected from contamination. The folks at Bob's Red Mill even took the time to explain on their label that some celiacs may not be able to tolerate them.

    The FDA is not expected to include oats as a prohibited grain for several reasons:

    • Lack of consensus amongst nutrition experts on exclusion of oats from the diet for celiac patients.
    • Research suggests that most celiac patients can tolerate oats that are manufactured in a gluten-free environment.
    • Oats  are good! They add texture, taste, fiber and nutrients to meals.
    • Adding a gluten-free label to SAFE oats will help consumers identify which brands are acceptable to purchase.
    • Potential incentive for manufacturers to produce gluten-free oats.

    Enforcement of Gluten-Free Standard:
    Although the FDA has not actually passed a standard yet, they have proposed a few ways to enforce the regulations once they go into effect. To enforce the new rules, the FDA has proposed conducting label reviews, on-site inspections of food manufacturers and analysis of food samples.

    Benefits of the Regulations:
    Once the regulations are enforced, people with celiac disease and those who maintain a gluten-free diet for other health conditions will be able to rest assured that products labeled “gluten-free” are in fact safe and held to a clear standard that is enforced by the FDA. Manufacturers will have a clear definition of the term “gluten-free” and be able to eliminate any confusion on how to label their products.

    The best part in my opinion is that the United States is catching up! U.S food producers will be on equal playing field with manufactures around the world. There will be no more confusion about what is considered gluten-free in the U.S. compared with other countries.

    NFCA Partners with Bob’s Red Mill for Gluten-Free Educational Webinar

    To showcase how the world is responding to the growth and need for regulations, the National Foundation for Celiac Awareness partnered with Bob’s Red Mill on a fabulous webinar project. On August 5th, we hosted the webinar to educate lifestyle and news media about celiac disease, the gluten-free diet and the future of food labeling laws both domestically and internationally.

    The panelists for the event included Dr. Aline Charabaty of Georgetown University Medical Center, Chef Edgar Steele of Cafe Atlantico,  Matt Cox from Bob's Red Mill, and yours truly! I spoke about the recent gluten-free labeling standards passed by Codex, a joint body of the WHO. I also spoke about how the U.S. FDA is expected to handle gluten-free labeling in the future. The panel was moderated by NFCA Executive Director Alice Bast.

    The webinar was a HUGE success and you can watch the entire thing on the Bob's Red Mill Website. WATCH THE WEBINAR.

    I've always known that Bob's Red Mill is a top-notch company, but after visiting the mill, I'm even more convinced that they are the cream of the crop! They truly take the business of providing gluten-free food seriously and it is 100% evident as you tour their facility.

    You can watch the entire webinar at the following web address: Watch the Webinar

    Study Identifies Celiac Disease Receptor

    New research may help patients get diagnosed with celiac disease sooner, cutting down on the average time of 10 years to get an accurate diagnosis. A study published in the July 2008 issue of the journal Gastroenterology finds and identifies a key gluten receptor in the small intestine that opens the gateway through which gluten enters the body and triggers the immune response in celiac patients.

    The study was conducted by researchers at the University of Maryland School of Medicine’s Center for Celiac Research and led by Dr. Alessio Fasano, professor of Pediatrics, Medicine and Physiology for the center.

    According to the researchers, the study answers a “fundamental question relating to the cause of celiac disease and , possibly other autoimmune disorders such as Type 1 diabetes and multiple sclerosis.”

    Dr. Fasano says that the identified receptor--known as CXCR3--is “critical to the early stages of the faulty immune response” and notes that its discovery could help physicians treat celiac disease more effectively.

    According to the study, gliadin--the part of gluten that causes a problem for patients with celiac disease--binds to the CXCR3 receptor. The interaction between the two (gliadin and CXCR3) leads to the release of a protein called zonulin. This protein “opens the intestinal barrier to make it more permeable.”

    For healthy patients the reaction is temporary and non-harmful, but for people with celiac disease the long-term damage can be detrimental.

    Dr. Fasano says the same process may occur in patients with multiple sclerosis and type 1 diabetes. “For the first time, we have evidence of how the foreign antigen gains access to the body, causing the autoimmune response.

    He notes that additional research is necessary, but adds that the findings could help prevent the     immune response amongst patients with celiac and other diseases in the future.

    In an article published in the Baltimore Sun, Dr. Peter Green, the director of the Celiac Disease Center at Columbia University and a spokesman for the American Gastroenterological Association commented on the study, saying it is “extensive and well-designed,” but notes that it remains “unclear how this research fits into scientists’ understanding of all the mechanisms of damage in celiac disease, because it involves various pathways.”

    May 21, 2008

    DDW: Day 3 Early Morning Celiac Session

    First thing this morning, celiac experts filled room 32 of the San Diego Convention Center to talk about the latest advances in celiac disease. Dr. Bob Anderson from Australia explored basic scientific advances and had some very interesting things to point out.

    • Researchers estimate that 5% of celiac patients in the United States are now correctly diagnosed. That doesn't sound like a lot, but considering that last year there was only 1%, this is a huge improvement! Only 95% more to go! Thank goodness for awesome awareness campaigns.
    • 20% of celiac patients are correctly diagnosed in Australia, UK, and Sweden.
    • 50% of celiac patients are diagnosed in Finland...they must be doing something right!
    • The most common path to diagnosis is through a gastroenterologist.
    • Diagnosis is confirmed through an invasive intestinal biopsy.
    • Today, the only treatment is a gluten-free diet.

    After presenting the State of Celiac Disease Today, Dr. Anderson hypothesized about where celiac disease will be in 10 years. Here's what he predicts:

    • More than 50% of celiac patients in the United States will be correctly diagnosed.
    • Primary care physicians will lead the charts in number of diagnoses.
    • There will be non-invasive methods to accurately diagnose celiac disease. This means a change in the gold standard.
    • Treatment will include both drugs and/or a gluten-free diet.
    • The gluten-free diet will be considered normal.
    • Physicians will be able to predict responses in patients.

    Dr. Anderson also listed priorities for celiac researchers including preventing the disease, improving treatment methods and promoting collaboration amongst researchers, industry and advocacy groups. He also suggested that better diagnostic tools will be developed including rapid tests and more specific blood tests.

    All of this information is tremendously exciting and gives hope to all of us with celiac disease. New researcher is emerging everyday and someday, maybe....we will find a cure!